financetom
Business
financetom
/
Business
/
PRESS DIGEST- Financial Times - March 24
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PRESS DIGEST- Financial Times - March 24
Mar 23, 2025 8:24 PM

March 24 (Reuters) - The following are the top stories

in the Financial Times. Reuters has not verified these stories

and does not vouch for their accuracy.

Headlines

- Wood Group poised to extend takeover talks with UAE's

Sidara

- National Grid chief says Heathrow had 'enough power'

despite fire shutdown

- Malaysia to crack down on Nvidia ( NVDA ) chip flows under US

pressure

- James Hardie to buy building products group Azek ( AZEK ) for

nearly $9bn

Overview

- British oilfield services and engineering firm Wood Group

has agreed to extend a deadline for talks with

Dubai-based Sidara for a possible takeover offer after a failed

attempt six months ago.

- National Grid's chief executive John Pettigrew has

insisted the electricity transmission network remained capable

of feeding enough power to Heathrow throughout the airport's

closure last week, as airlines' anger over the decision to shut

down for nearly 24 hours grew.

- Malaysian trade minister Zafrul Aziz said Washington was

demanding Malaysia closely track the movement of high-end Nvidia ( NVDA )

chips that enter the country over suspicions that many

are ending up in China, in violation of U.S. export rules.

- Fibre-cement maker James Hardie Industries ( JHX ) said

it would acquire U.S. outdoor building products maker AZEK

Company ( AZEK ) in a cash and stock deal worth $8.75 billion

including debt, looking to boost growth with new offerings to

homeowners.

(Compiled by Bengaluru newsroom)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Natera's H2 Guidance Leaves 'Ample Room' for Upside, Morgan Stanley Says
Natera's H2 Guidance Leaves 'Ample Room' for Upside, Morgan Stanley Says
Aug 13, 2024
11:19 AM EDT, 08/13/2024 (MT Newswires) -- Natera ( NTRA ) reported better-than-expected Q2 revenue on volume growth and average selling price momentum, but its second-half outlook leaves ample room for upside, Morgan Stanley said in a note e-mailed Tuesday. Late Thursday, the company posted Q2 revenue of $413.4 million, up from $261.4 million a year earlier. Analysts polled by...
Update: Chipotle's Shares Plunge After Board Names COO Scott Boatwright as Interim CEO
Update: Chipotle's Shares Plunge After Board Names COO Scott Boatwright as Interim CEO
Aug 13, 2024
11:19 AM EDT, 08/13/2024 (MT Newswires) -- (Updates with stock price movement in the headline and first paragraph.) Chipotle Mexican Grill's ( CMG ) Shares fell over 10% in recent trading on Tuesday after the company said its board has appointed Chief Operating Officer Scott Boatwright as interim chief executive, effective Aug. 31. Current CEO Brian Niccol is leaving the...
Update: Tencent Music Entertainment Shares Drop After Q2 Revenue Falls
Update: Tencent Music Entertainment Shares Drop After Q2 Revenue Falls
Aug 13, 2024
11:20 AM EDT, 08/13/2024 (MT Newswires) -- (Updates with latest stock movement in the headline and first paragraph.) Tencent Music Entertainment Group ( TME ) shares dropped nearly 16% in recent Tuesday trading after the company reported lower Q2 revenue. Tencent reported Q2 earnings premarket of 1.07 Chinese renminbi ($0.15) per diluted American depositary share, up from 0.82 renminbi a...
Adial Signs Deal With Boudicca to Advance Regulatory Strategy for Companion Diagnostic Genetic Test
Adial Signs Deal With Boudicca to Advance Regulatory Strategy for Companion Diagnostic Genetic Test
Aug 13, 2024
11:20 AM EDT, 08/13/2024 (MT Newswires) -- Adial Pharmaceuticals ( ADIL ) said Tuesday it is partnering with Boudicca Dx to progress regulatory strategy for its companion diagnostic genetic test for its lead investigational asset, AD04, a therapeutic agent for the treatment of Alcohol Use Disorder. Boudicca will help ensure it is validated both technically and clinically per the US...
Copyright 2023-2026 - www.financetom.com All Rights Reserved